Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 8.724% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. Cc1ccc(C(=O)NC2CCN(C(=O)N3CCOCC3)CC2)cc1
b. COc1ccc(-n2nc3c(N4CCC(C(=O)NCc5ccccc5)CC4)nnc(C)c3c2C)cc1
Answer: a. Cc1ccc(C(=O)NC2CCN(C(=O)N3CCOCC3)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(C(=O)NC2CCN(C(=O)N3CCOCC3)CC2)cc1
Cc1ccc(C(=O)NC2CCN(C(=O)N3CCOCC3)CC2)cc1
4-methyl-N-[1-(morpholine-4-carbonyl)piperidin-4-yl]benzamide